Back to LAZARD ASSET MANAGEMENT LLC LAZARD ASSET MANAGEMENT LLC

SRNESRNE

Showing 0 of 8 quarters

Position history for LAZARD ASSET MANAGEMENT LLCLAZARD ASSET MANAGEMENT LLC's holdings in SORRENTO THERAPEUTICS INC

As of its Q4 2022 13F, Lazard Asset Management held 40,229 shares of SRNE (Sorrento Therapeutics), worth $35,000.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used